Every Medical Research story tagged Regulation.
STAT introduces a new initiative focused on trust in science, hiring Nicholas Florko as a dedicated reporter to explore misinformation, its origins, and its impact. The initiative will also include essays and profiles, supported by multiple foundations, and will be a key theme at the upcoming STAT Summit.
Regeneron Pharmaceuticals' Pasatru has earned FDA approval for treating fibrodysplasia ossificans progressiva, a rare condition causing abnormal bone growth.
A nonprofit group is suing the Trump administration over the process of updating the nation's dietary guidelines, alleging that the government improperly rewrote the guidelines with the help of a 'secret panel' of scientists backed by the beef and dairy industries.
Epic Systems, the nation's dominant seller of electronic health records software, is facing a series of unprecedented challenges driven by antitrust lawsuits, questions about its artificial intelligence strategy, and an exodus of key technology leaders.
Health Secretary Robert F. Kennedy Jr. recently visited California to discuss changes to addiction treatment, placing blame on the prior administration for handling the issue.
The U.S. FDA has approved Bristol Myers Squibb’s oral drug iberdomide, marketed as Zenbexus, for use with daratumumab and dexamethasone in patients with relapsed or refractory multiple myeloma, marking the first approval of a novel drug class for the disease and the inaugural use of a more sensitive remission endpoint in the United States.
The Federal Trade Commission is examining Epic Systems Corp. for potential violations of antitrust law, focusing on the company's business practices and agreements that may be limiting competition in the electronic health records market.